drugset / Trial / NCT01099748

Estimate The Effect Of Lersivirine On The Pharmacokinetics Of S- And R-Methadone

NCT01099748

Phase 1 Completed 13 enrolled Pfizer
Non-randomizedCrossoverOpen-labelTreatment

Summary

The objective of this study is to estimate the effect of lersivirine on the pharmacokinetics of R-methadone and S-methadone and to investigate the safety and tolerability of lersivirine when co-administered with methadone. Symptoms of methadone withdrawal will also be assessed.

Timeline

Start
2010-05
Primary completion
2010-06
Completion
2010-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Lersivirine Small molecule 1000 mg
Comparator Methadone Other / unclassified 50 mg
Comparator Methadone Other / unclassified 150 mg

Indications

No indication recorded.